Nexavar
Contact Us Site Map Search
  • Home
  • Nexavar for HCC
  • Nexavar for Advanced RCC
  • Nexavar Mechanism of Action
  • Professional Resources
Product Summary
Essential Information
Summary of Product Characteristics/ Prescribing Information
HCC Clinical Experience Presentations
RCC Clinical Experience Presentations
Bayer Links
Bayer Global
Bayer Pharma
Bayer HealthCare
  • General Conditions of Use
  • Privacy Statement
  • Imprint
Copyright ©
Bayer Pharma AG
Your browser does not support flash 8 or later which is needed to view this animation. Please visit www.macromedia.com/go/getflashplayer to download the flash player.
Site Map
- + Text Zoom
Nexavar for HCC
  • Overview of HCC
  • HCC Risk Factors
  • Pivotal Study: The SHARP Trial
  • Nexavar Efficacy in HCC
  • Nexavar Safety in HCC
  • Dosing Information
  • References
Nexavar for Advanced RCC
  • TARGET Phase III Clinical Trial Design and Results
  • Efficacy
  • Safety Profile
  • Dosing Information
  • Advanced RCC Nurse Guide and FAQ
  • References
Nexavar Mechanism of Action
  • The RAS/RAF/MEK/ERK Pathway and HCC
  • Uncontrolled Activation of the RAF/MAP/ERK Pathway
  • Rationale for Targeted Therapy in Advanced RCC
  • References
Professional Resources
  • Advanced RCC Nurse Guide and FAQ
  • Clinical Trials
  • Online Resources
 
Term
Explanation for term.
Printer-friendly version   Email this page